|
MechanismPurinergic P2 receptor antagonists [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Phenoquest AG
0 Patents (Medical) associated with Phenoquest AG
100 Deals associated with Phenoquest AG
100 Translational Medicine associated with Phenoquest AG